Davis Polk

Samantha Lefland

Deals
3
Latest
Jun 2026

Firm

Deals by year
Samantha Lefland: deals by year0320252026 YTD: 3 M&A32026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Samantha Lefland was named on, most recent first
Jun 2026 SAGA Diagnostics –RocheAcquisitionLegal adviser to Roche (acquirer)Announced595.0Diagnostics+1Roche acquisition of SAGA Diagnostics
May 2026 PathAI –RocheAcquisitionLegal adviser to Roche (acquirer)Pending750.0Healthcare Software+2Roche acquisition of PathAI
Jan 2026 AbelZeta's 50% share of China development and commercialisation rights to C-CAR031 AbelZetaAstraZenecaAsset saleLegal adviser to AbelZeta (target)Announced630.0Biotech+2AstraZeneca acquisition of AbelZeta's 50% share of China development and commercialisation rights to C-CAR031

Deals where Samantha Lefland is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.